Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novo Integrated Sciences, Inc. - Common Stock (NQ: NVOS )

0.1490 UNCHANGED
Last Price Updated: 4:00 PM EST, Nov 5, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Novo Integrated Sciences, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Why Is Novo Integrated Sciences (NVOS) Stock Up 139% Today?
Novo Integrated Sciences stock is up on Friday as NVOS investors are excited about the company increasing its share buyback program. 
Via InvestorPlace
Nasdaq Down 1.5%; Gap Shares Spike Higher
Via Benzinga
US Stocks Mostly Higher; Headline PCE Inflation Matches Estimates
Via Benzinga
Topics Economy
Exposures Interest Rates
Novo Integrated Sciences’ Board of Directors Conducting Strategic Review to Increase Maximum Amount under Stock Repurchase Program
From Novo Integrated Sciences, Inc.
Via Business Wire
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Why Zscaler Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
It's time to start the final day of trading this week with a breakdown of the biggest pre-market stock movers on Friday morning! 
Via InvestorPlace
Novo Integrated Sciences Shares Surge 70% After Company Secures $78M Funding From HSBC For Acquisition Of Ophir Collection
Novo Integrated Sciences surged 70.29% in after-hours trading to $0.77 following HSBC's confirmation of a $78 million Standby Letter of Credit. 
Via Benzinga
Novo Integrated Sciences Receives Confirmation of Ready, Willing and Able (RWA) Issued by HSBC for SBLC Leasing and Monetizing Program
From Novo Integrated Sciences, Inc.
Via Business Wire
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
NVOS Stock Earnings: Novo Integrated Sciences Reported Results for Q2 2024
Novo Integrated Sciences just reported results for the second quarter of 2024. 
Via InvestorPlace
Novo Integrated Sciences Reports Fiscal Year 2024 Second Quarter Financial Results
From Novo Integrated Sciences, Inc.
Via Business Wire
Novo Integrated Sciences Closes on $6,210,000 Securities Purchase Agreement
From Novo Integrated Sciences, Inc.
Via Business Wire
Why Rallybio Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket
Shares of Rallybio Corporation (NASDAQ: RLYB) rose sharply in today’s pre-market trading after the company announced a collaboration with Johnson & Johnson to advance therapeutics for pregnant... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Novo Integrated Sciences Provides Update on Certain Current Actions and Events
From Novo Integrated Sciences, Inc.
Via Business Wire
Novo Integrated Sciences Subsidiary, Clinical Consultants International, Signs Agreement with Futura Surgicare Pvt Ltd.
From Novo Integrated Sciences, Inc.
Via Business Wire
Novo Integrated Sciences Receives Limited Waiver to Securities Purchase Agreement for $70,000,000 Promissory Note
From Novo Integrated Sciences, Inc.
Via Business Wire
Novo Integrated Sciences Appoints New President
From Novo Integrated Sciences, Inc.
Via Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Novo Integrated Sciences Reports Fiscal Year 2024 First Quarter Financial Results
From Novo Integrated Sciences, Inc.
Via Business Wire
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Blacksheep Trust Files Partial Assignment of $1 Billion Dollar Gold Backed Bond to Novo Integrated Sciences
From Novo Integrated Sciences, Inc.
Via Business Wire
NVOS Stock Earnings: Novo Integrated Sciences Reported Results for Q4 2023
Novo Integrated Sciences just reported results for the fourth quarter of 2023. 
Via InvestorPlace
Novo Integrated Sciences Reports 2023 Fiscal Year Financial Results
From Novo Integrated Sciences, Inc.
Via Business Wire
Novo Integrated Sciences Signs Master Collaboration Agreement with Psychocare Health Pvt. Ltd. India
From Novo Integrated Sciences, Inc.
Via Business Wire
Novo Integrated Sciences Regains Compliance with Nasdaq Minimum Bid Price Requirement
From Novo Integrated Sciences, Inc.
Via Business Wire
Novo Integrated Sciences’ Purchase and Sale Agreement to Acquire Ophir Collection Receives Court Approval
From Novo Integrated Sciences, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.